Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics
Its important to remember that both of these medications have been approved by medical experts and are considered safe for use in the right patients
This results in an overloaded immune system and a heightened immune response
CrossRef Metformin usage and the risk of colorectal cancer: a national cohort study Jae-woo Lee, Eun-A Choi, Ye-Seul Kim, Yonghwan Kim, Hyo-Sun You, Ye-Eun Han, Hyeong-Seop Kim, Yoon-Jong Bae, Joungyoun Kim, Hee-Taik Kang International Journal of Colorectal Disease.2021
(Practice point) For patients in whom additional glucose-lowering may increase risk for hypoglycemia (e.g., those treated with insulin or sulfonylureas and currently meeting glycemic targets), it may be necessary to stop or reduce the dose of an antihyperglycemic drug other than metformin to facilitate addition of an SGLT2i